specialising in pharmaceutical intermediates and speciality chemicals.Evolution of Business The company is changing its focus from Intermediates for Off-patent and generic drugs towards patented molecules requiring strong technical know how. The revenue contribution from Intermediates has also shifted from 90% to <60%.
No Pledging announcements from Shree Ganesh Remedies Ltd yet.
